术前戒烟对主髂动脉闭塞性疾病择期腹股沟上旁路术结局的影响:倾向性评分匹配分析
基于VQI数据库2009-2023年择期腹股沟上旁路术病例,经倾向性评分匹配比较活动性吸烟者与戒烟≥1个月者。活动性吸烟与呼吸系统并发症风险升高及1年、3年死亡风险增加相关,尤其在慢性肢体威胁性缺血患者中。
要点
- 择期腹股沟上旁路术前活动性吸烟增加呼吸系统并发症风险(OR 1.34)。
- 活动性吸烟与1年(aHR 1.76)和3年(aHR 1.68)死亡风险升高相关。
- 慢性肢体威胁性缺血患者中活动性吸烟者3年死亡风险显著升高(aHR 1.67)。
核心结论
- 择期腹股沟上旁路术时活动性吸烟与呼吸系统并发症增加及长期生存更差相关,尤其在慢性肢体威胁性缺血患者中。
研究设计与样本
- 回顾性分析Vascular Quality Initiative数据库2009-2023年择期腹股沟上旁路术病例,行1:1倾向性评分匹配,活动性吸烟者与戒烟≥1个月者各4831对。
主要发现
- 活动性吸烟与30天死亡、心肌梗死、手术部位感染或大截肢/再干预无显著关联。
临床怎么用
- 应将戒烟作为腹股沟上血运重建围手术期风险优化的重要环节。
- 对慢性肢体威胁性缺血患者尤其应优先强调术前戒烟以改善长期生存。
局限性
- 原文未报告具体局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Smoking cessation before elective surgery is generally recommended to reduce cardiovascular and respiratory risk as well as achieving favorable outcomes. This study aimed to evaluate the impact of preoperative smoking cessation on the outcomes of elective suprainguinal bypasses (SIB) for aortoiliac occlusive disease using data from the Vascular Quality Initiative. METHODS: We retrospectively analyzed the Vascular Quality Initiative database (2009-2023) for elective SIBs for aortoiliac occlusive disease. Both claudication and chronic limb-threatening ischemia (CLTI) were included. A one-to-one propensity score matching (PSM) created two cohorts: active smokers (ASs) vs former smokers (FS). A FS was defined as quitting smoking ≥1 month before surgery. PSM was based on demographics, comorbidities, preoperative medications, prior procedures, indication for bypass, type of bypass, and concomitant procedures. Primary outcomes were 30-day, 1-year, and 3-year mortality. Secondary outcomes included postoperative complications, 1-year major amputation, reintervention, major adverse limb event, and combination of these events. One- and 3-year outcomes were adjusted for discharge medications and smoking status at follow-up. RESULTS: Before PSM, there were 6962 FS (41.8%) vs 9708 AS (58.2%) cases. FS patients were more likely to be older (66.7 years vs 61.4 years; P < .001), female (42.4% vs 40.3%; P = .007), have severe cardiovascular comorbidities, and undergo extra-anatomical bypass, whereas AS patients were more likely to have chronic obstructive pulmonary disease (39.2% vs 34.2%; P < .001) and present with CLTI (51.3% vs 46.6%; P < .001). After PSM, we created 4831 pairs of FS and AS cases. Active smoking was associated with an increased risk of respiratory complications (odds ratio [OR], 1.34; 95% confidence interval [CI], 1.11-1.62; P = .002), but not with 30-day mortality, myocardial infarction, surgical site infection, or major amputation/reintervention. Additionally, AS had increased hazards for death at 1 year (adjusted hazard ratio [aHR], 1.76; 95% CI, 1.10-2.81; P = .018) and 3 years (aHR, 1.68; 95% CI, 1.26-2.28; P < .001). In a subanalysis of outcomes based on presentation, AS was associated with increased risk of respiratory complications in both claudication (OR, 1.35; 95% CI, 1.03-1.77; P = .029) and CLTI (OR, 1.34; 95% CI, 1.02-1.75; P = .032). However, in survival analysis, AS had an increased hazard of 3-year death only in patients with CLTI (aHR, 1.67; 95% CI, 1.19-2.36; P = .003). CONCLUSIONS: Active smoking at the time of elective SIB was associated with increased respiratory complications and worse long-term survival, particularly among patients with CLTI. These findings support prioritizing smoking cessation as part of perioperative risk optimization in patients undergoing suprainguinal revascularization. Further studies are needed to evaluate the impact of longer durations of preoperative cessation on postoperative outcomes.
引用
- Rahgozar S, Zarrintan S, Hamouda M, et al. The impact of preoperative smoking cessation on outcomes of elective suprainguinal bypasses in patients with aortoiliac occlusive disease: A propensity-score matched analysis. J Vasc Surg. 2026. PMID: 41903721. doi:10.1016/j.jvs.2026.03.440
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。